Controversy and debate on dengue vaccine series —paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs

In their response to our critique [1] of their article, Hadinegoro et  al. question us on three issues [2].

Source: Journal of Clinical Epidemiology - January 3, 2018 Category: Epidemiology Authors: Antonio L. Dans, Leonila F. Dans, Mary Ann D. Lansang, Maria Asuncion A. Silvestre, Gordon H. Guyatt Tags: Controversy and Debate on Dengue Vaccine Series Source Type: research